Patent · US Active

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

US10239937B2 · kind B2 · utility

0Cited by

39References

33Claims

0Family size

Assignee

Alexion Pharmaceuticals, Inc. · US

Inventors

V. Michael Holers · Denver, US
Antonio Risitano · Catania, IT

Key dates

Filing date	Nov 5, 2010
Grant date	Mar 26, 2019
Priority date	—
Expiry date	Nov 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for treating subjects having complement-mediated hemolytic disorders, such as paroxysmal nocturnal hemoglobinuria (PNH) and other hemolytic anemias, the method comprising administering an effective amount of a composition that inhibits the activity of the complement alternative pathway.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.